Dr Robin Corey
BSc, MSc, PhD
Expertise
Computational biophysicist/pharmacologist at the University of Bristol | GPCRs | Ion channels | Molecular dynamics | Molecular modelling | Free energy calculations | Python | Coarse-grained simulations
Current positions
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
I studied Biochemistry at the University of York, before moving to Bristol to carry out a PhD in Bristol. Here I used experimental techniques and molecular modelling to help undestand protein secretion in bacteria as a part od Ian Collinson's lab.
Following this, I moved to the University of Oxford to work with Mark Sansom and Phill Stansfeld for a 5 year PDRA to consolidate my molecular modelling expertise. This includes developing specialized tools and protocols for molecular modelling of membrane proteins.
I joined the School of Physiology, Pharmacology, and Neuroscience in July 2023 as a lecturer. Here I research and teach on understanding the biology and pharmacology of membranes proteins such as GPCRs and ion channels using molecular modelling and AI.
Following this, I moved to the University of Oxford to work with Mark Sansom and Phill Stansfeld for a 5 year PDRA to consolidate my molecular modelling expertise. This includes developing specialized tools and protocols for molecular modelling of membrane proteins.
I joined the School of Physiology, Pharmacology, and Neuroscience in July 2023 as a lecturer. Here I research and teach on understanding the biology and pharmacology of membranes proteins such as GPCRs and ion channels using molecular modelling and AI.
Projects and supervisions
Thesis supervisions
Mechanistic Insights into GPCR Dimerisation
Supervisors
Publications
Recent publications
14/01/2026Insights from aquaporin structures into drug-resistant sleeping sickness
eLife
In silico discovery and characterisation of a novel nuclear transcription factor-Y (NF-Y) inhibitor with anti-mitogenic properties
Journal of Medicinal Chemistry
Transmembrane domain switching controls PINK1 import and fate in mitochondria
The EMBO journal
Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization
eLife
Noncanonical pharmacological inhibition of the hERG K+ channel by a synthetic cannabinoid
Biochemical Pharmacology
Related people
Dr Hongwei Cheng
Senior Research Associate
Bristol Medical School (THS)
Dr William Allen
Senior Research Associate
School of Biochemistry
Professor Eamonn Kelly
Professor of Molecular Pharmacology
School of Physiology, Pharmacology & Neuroscience
Professor Ian Collinson
Professor of Biochemistry
School of Biochemistry